Project Details
Description
A PIVOTAL, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, INTERNATIONAL PHASE III CLINICAL TRIAL TO INVESTIGATE THE EFFICACY AND SAFETY OF ALLO-APZ2-CVU ON WOUND HEALING OF THERAPY-RESISTANT NON-HEALING CHRONIC VENOUS ULCERS (CVU)
Status | Active |
---|---|
Effective start/end date | 6/3/24 → 6/2/25 |
Funding
- RHEACELL GMBH & CO KG
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.